John Frederick Boylan
18Patents
4h-index
42Co-inventors
60Inventor score
Filing activity: Jul 19, 2001 → Jan 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9512124B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 24 | Active |
| US9737541B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 9 | Active |
| US9346812B2 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 5 | Active |
| US9428509B2 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 4 | Active |
| US6881542B1 | Serine threonine kinase member, h2520-59 | Chemistry; Metallurgy | 2 | Expired |
| US10940152B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 1 | Active |
| US10646493B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 1 | Active |
| US8741889B2 | Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor | Chemistry; Metallurgy | 1 | Active |
| US11920134B2 | Compositions and methods for inhibiting expression of RRM2 genes | Chemistry; Metallurgy | 0 | Active |
| US9795607B2 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
| US8309299B2 | Combination therapy and method for assessing resistance to treatment | Physics | 0 | Active |
| US10576085B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Human Necessities | 0 | Active |
| US10619160B2 | Compositions and methods for inhibiting expression of RRM2 genes | Chemistry; Metallurgy | 0 | Active |
| US8946176B2 | Compositions and methods for inhibiting expression of RRM2 genes | Chemistry; Metallurgy | 0 | Active |
| US9623028B2 | Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof | Human Necessities | 0 | Active |
| US9938531B2 | Compositions and methods for inhibiting expression of RRM2 genes | Chemistry; Metallurgy | 0 | Active |
| US7029892B1 | Serine threonine kinase member, h2520-59 | Chemistry; Metallurgy | 0 | Expired |
| US11590139B2 | Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.